Torque Teno Virus: A Biomarker of Immunosuppression

计划入组 268 人 · 首次发布于 2023 年 3 月 6 日

Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study

计划入组 172 人 · 首次发布于 2023 年 5 月 1 日

Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients

计划入组 90 人 · 首次发布于 2025 年 5 月 13 日

Ebola virus vaccine (Profectus Biosciences)

influenza virus vaccine

Measles virus vaccine live attenuated(M-M-R II, Proquad)

Assembly Biosciences

United States

AbbVie CDR (CAD Hedged)

United States

Enanta Pharmaceuticals

United States

Biomarker-Guided Immunosuppression Shows Safety in Kidney Transplant: TTVguideIT Phase II Trial Meets Primary Endpoint

FDA approves oncolytic virus

RSV Vaccine Safety Profile Monitored Across Age Groups and Populations